Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Alerting Liver Damage Caused by Lead Poisoning Accompanied by Abdominal Pain and Anemia: Diagnostic and Treatment Approach of a Rare Case

    Authors: Liang Zhang, Jianping Qin, Shanhong Tang Institution: Department of Gastroenterology, General Hospital of Western Theater Command Thematic Review Lead is a toxic heavy metal primarily absorbed through the respiratory…

    2024.09.08
  • Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B

    1. HBsAg Clearance Significantly Reduces the Risk of HCC and End-Stage Liver Disease in CHB Patients A study in Chinese Taiwan recruited patients with CHB-related liver cirrhosis who achieved virological…

    2024.09.08
  • Can Expired Blood Culture Bottles Still Be Used?

    In resource-limited settings, the use of medical equipment is often restricted by expiration dates and storage conditions. However, new research conducted by the Institute of Tropical Medicine (ITM) in Antwerp,…

    2024.09.08
  • Dr. Yue Lu: A Review and Update on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare malignancy of the hematopoietic system, is distinguished by its highly recognizable skin manifestations and complex pathophysiology, which continue to captivate the medical community’s investigative spirit and challenge its resolve. Recently, Dr. Yue Lu from Lu Daopei Medical provided an in-depth analysis of BPDCN’s origins, clinical presentation, diagnostic…

    2024.09.08
  • Mutual Learning Between China and Germany丨International Perspectives, Leading the Frontier: The Academic Journey of Dr. Jürgen Wolf from the Universit

    With an international perspective and a focus on leading-edge advancements, the Overseas Experts China Tour project welcomed a prominent figure in the field of lung cancer from August 5th to 10th, 2024—Dr. Jürgen Wolf, Director of the Centre for Integrated Oncology (CIO) at University Hospital of Cologne, Professor of Interdisciplinary Translational Oncology at the University…

    2024.09.08
  • Dr. Zhizhong Pan: The Journey of Colorectal Cancer Immunotherapy Research—Experiences from Sun Yat-sen University Cancer Center丨Guangzhou Colorectal Cancer Summit Forum

    At the Guangzhou Colorectal Cancer Summit Forum and the 22nd Guangdong Colorectal Cancer Academic Conference held from August 5-10, 2024, Dr. Zhizhong Pan from Sun Yat-sen University Cancer Center delivered an insightful presentation titled “The Journey of Colorectal Cancer Immunotherapy Research: Experiences from Sun Yat-sen University Cancer Center.” After the conference, Professor Pan granted us…

    2024.09.08
  • Insights from Hematology Expert | Dr. Jianxiang Wang: Delving into Immune Mechanisms to Pioneer New Target Frontiers

    The breakthrough achievements of CAR-T therapy in the field of hematologic malignancies are remarkable. However, challenges such as target limitations, limited cell sources, and durability of efficacy continue to necessitate further exploration. Dr. Jianxiang Wang’s team at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences , stands as a pioneer…

    2024.09.05
  • Dr. Ruiyun Zhang: New Approaches Like Targeted Immunotherapy and ctDNA Further Address the Bladder-Preserving Needs of MIBC Patients | 2024 ASCOBT

    The ASCO Breakthrough Summit, held from August 8th to 10th in Yokohama, Japan, focused on new technologies in cancer treatment and shared breakthrough advances and research that are driving global cancer treatment forward. The research titled “Preliminary results of an open-label, single-arm, multi-center study on disitamab vedotin (DV) combined with toripalimab and radiotherapy as bladder-preserving…

    2024.09.05
«previous next»
Recent Posts
  • the 14th Lu Daopei Hematology Forum丨Professor Xian Zhang: Reshaping the Treatment Landscape Through Precision Stratification — Advances in Immunotherapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
  • the 14th Lu Daopei Hematology Forum丨Professor Yuzhu Shi: Identifying Etiology Through Imaging for Precise Diagnosis — Imaging Diagnosis of Central Nervous System Infections After Hematopoietic Stem Cell Transplantation
  • 2026 Pujiang Urological Oncology Conference丨Professor Gang Zhu: AI and Holographic Imaging Empower Urologic Oncology Surgery — From Precision Resection to Functional Preservation
  • AIDS 2026 | Interview with Dr. Claire Norcross: Analysis of HIV Drug Resistance Profiles and Implementation Strategies for Long-Acting Antiretroviral Regimens in African Populations
  • AIDS 2026 | Adriana Cervo: Focus on Long-Term Survival, Tumor Recurrence and Post-Transplant Metabolic Management Among HIV-Infected Liver Transplant Recipients
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top